IL109866A - Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it - Google Patents

Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it

Info

Publication number
IL109866A
IL109866A IL10986694A IL10986694A IL109866A IL 109866 A IL109866 A IL 109866A IL 10986694 A IL10986694 A IL 10986694A IL 10986694 A IL10986694 A IL 10986694A IL 109866 A IL109866 A IL 109866A
Authority
IL
Israel
Prior art keywords
hydrogentartrate
thiadiazol
methylpyridine
hexyloxy
tetrahydro
Prior art date
Application number
IL10986694A
Other languages
English (en)
Other versions
IL109866A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL109866A0 publication Critical patent/IL109866A0/xx
Publication of IL109866A publication Critical patent/IL109866A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL10986694A 1993-06-04 1994-06-02 Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it IL109866A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7257293A 1993-06-04 1993-06-04

Publications (2)

Publication Number Publication Date
IL109866A0 IL109866A0 (en) 1994-10-07
IL109866A true IL109866A (en) 2000-06-01

Family

ID=22108479

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10986694A IL109866A (en) 1993-06-04 1994-06-02 Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it

Country Status (22)

Country Link
US (1) US5834495A (ko)
EP (1) EP0703915B1 (ko)
JP (1) JP3190679B2 (ko)
KR (1) KR100339115B1 (ko)
CN (1) CN1064681C (ko)
AT (1) ATE196631T1 (ko)
AU (1) AU698673B2 (ko)
CA (1) CA2164296C (ko)
CZ (1) CZ290550B6 (ko)
DE (1) DE69426021T2 (ko)
DK (1) DK0703915T3 (ko)
ES (1) ES2152315T3 (ko)
FI (1) FI955829A0 (ko)
GR (1) GR3035033T3 (ko)
HU (1) HUT75038A (ko)
IL (1) IL109866A (ko)
NO (1) NO305560B1 (ko)
NZ (2) NZ267062A (ko)
PT (1) PT703915E (ko)
SK (1) SK281980B6 (ko)
WO (1) WO1994029303A1 (ko)
ZA (1) ZA943904B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
EP0821956A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating disruptive behavior disorders
EP0821954A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating mental retardation
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
WO2016144719A1 (en) * 2015-03-06 2016-09-15 Chase Thomas N Oxybutynin transdermal therapeutic system muscarinic agonist combination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use

Also Published As

Publication number Publication date
WO1994029303A1 (en) 1994-12-22
JPH08511008A (ja) 1996-11-19
NZ267062A (en) 1999-09-29
DE69426021T2 (de) 2001-05-17
HU9503453D0 (en) 1996-01-29
KR100339115B1 (ko) 2002-11-07
AU698673B2 (en) 1998-11-05
EP0703915A1 (en) 1996-04-03
ES2152315T3 (es) 2001-02-01
SK152095A3 (en) 1996-10-02
CA2164296C (en) 2007-01-23
HUT75038A (en) 1997-03-28
FI955829A (fi) 1995-12-04
SK281980B6 (sk) 2001-09-11
FI955829A0 (fi) 1995-12-04
NO954892L (no) 1995-12-01
US5834495A (en) 1998-11-10
CA2164296A1 (en) 1994-12-22
CN1128999A (zh) 1996-08-14
NZ336733A (en) 2001-02-23
ZA943904B (en) 1995-12-04
CN1064681C (zh) 2001-04-18
AU6924294A (en) 1995-01-03
GR3035033T3 (en) 2001-03-30
CZ321095A3 (en) 1996-09-11
NO954892D0 (no) 1995-12-01
KR960702835A (ko) 1996-05-23
IL109866A0 (en) 1994-10-07
EP0703915B1 (en) 2000-09-27
JP3190679B2 (ja) 2001-07-23
NO305560B1 (no) 1999-06-21
DK0703915T3 (da) 2001-01-22
DE69426021D1 (de) 2000-11-02
CZ290550B6 (cs) 2002-08-14
ATE196631T1 (de) 2000-10-15
PT703915E (pt) 2001-03-30

Similar Documents

Publication Publication Date Title
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
HUP9700709A3 (en) 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds
IL116203A (en) Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron
IL103678A0 (en) Pyrazolylpyrazole derivatives,processes for the preparation thereof and herbicidal compositions containing the same
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
IL102682A0 (en) Benzenesulfonamide derivatives,processes for the preparation thereof and herbicidal compositions containing the same
NZ240378A (en) Substituted thiazolidinedione derivatives; pharmaceutical compositions,
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
ZA93196B (en) Composition for desensitizing teeth.
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
IL109275A0 (en) 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
HU9303113D0 (en) Pharmaceutical compositions containing 1,2-dithiol-3-thione-derivatives
IL109866A0 (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it
ZA92110B (en) Pharmaceutical compositions.
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
IL101835A0 (en) Benzothiazole derivatives,processes for the preparation thereof,and herbicidal compositions containing the same
ZA931593B (en) 2,4-Thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them.
ZA918381B (en) Pharmaceutical compositions.
TW218011B (ko)
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
AU610456B2 (en) 4-ethyl-3-(substituted phenyl)-1-(3-trifluoromethylphenyl) -2-pyrrolidinone derivatives, processes for the preparation and use thereof, herbicidal compositions containing them
HUP9800032A3 (en) 3-aryluracil-derivatives, preparation and use thereof, herbicidal compositions containing these compounds and preparation of the latest

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees